The prevention of ischemia-induced changes in Gi-mediated signal transduction and/or (with certain limitations discussed below) the selective activation of cardiac muscarinic M2 receptors could hence be an alternative pharmacological treatment for acute myocardial ischemia [67]. The gene discussed is GNAI1; the disease is ischemia.